Identifying individuals at high risk for common diseases using genomic data.
Vanderbilt Genome-Electronic Records (VGER) Project
['FUNDING_U01'] · VANDERBILT UNIVERSITY MEDICAL CENTER · NIH-10850837
This study is looking for people who might be at higher risk for common diseases like heart disease and diabetes, using advanced tools that analyze genetic and health information, so we can help them with early detection and personalized health plans.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY MEDICAL CENTER (nih funded) |
| Locations | 1 site (NASHVILLE, UNITED STATES) |
| Trial ID | NIH-10850837 on ClinicalTrials.gov |
What this research studies
This research aims to enhance Precision Medicine by identifying individuals who are at high risk for common diseases through advanced genomic risk assessment tools. By analyzing large datasets that include genetic information, family health history, and clinical predictors, the project seeks to develop tools that can help in early detection and prevention of diseases such as coronary artery disease and diabetes. The initiative will engage participants and communities to ensure that the findings are relevant and beneficial. Ultimately, the goal is to provide personalized health strategies based on individual risk profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a family history of coronary artery disease or diabetes, as well as those interested in understanding their genetic risk factors.
Not a fit: Patients without a family history of the targeted diseases or those who do not wish to participate in genomic assessments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention and early treatment strategies for individuals at high risk of certain diseases.
How similar studies have performed: Previous research in genomic risk assessment has shown promise in identifying high-risk individuals and improving health outcomes, indicating that this approach is both viable and potentially impactful.
Where this research is happening
NASHVILLE, UNITED STATES
- VANDERBILT UNIVERSITY MEDICAL CENTER — NASHVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RODEN, DAN M — VANDERBILT UNIVERSITY MEDICAL CENTER
- Study coordinator: RODEN, DAN M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Coronary Artery Disease, Coronary Artery Disorder, atherosclerotic coronary disease, coronary arterial disease, Adult-Onset Diabetes Mellitus